As a journalist, every new story is a unique opportunity to inform and educate the public on the current happenings. A recent development has brought to light an important issue in the world of health and wellness that deserves our attention.

According to new research published in the Journal of Clinical Oncology, a majority of breast cancer patients do not undergo recommended genetic testing for cancer risk. Genetic testing for cancer risk is an essential step in determining the appropriate treatment and prevention plans for those who have been diagnosed with breast cancer.

The research, which surveyed over 1,500 women with breast cancer, found that only one in five patients underwent multigene panel testing, despite it being recommended by medical professionals. The panel can identify mutations in multiple genes that can increase the risk of cancer, giving doctors a more comprehensive understanding of a patient’s risk and allowing them to make more informed treatment decisions.

The study’s lead author, Dr. Allison Kurian, notes that this lack of testing may be due in part to inadequate access to genetic counselors, who can provide important guidance and education about genetic risks and testing options.

This research highlights the need for greater awareness and access to genetic testing for breast cancer patients, ensuring that they receive the best possible care and treatment options. Genetic testing can help patients and doctors make informed decisions about surgery, chemotherapy, and radiation therapy.

Breast cancer is the most common form of cancer in women worldwide, and the second most common cancer overall. With this new information, it is important that patients with breast cancer take advantage of available genetic testing to ensure that they receive appropriate care.

In conclusion, the importance of genetic testing for breast cancer patients cannot be overstated. Fortunately, there are steps being taken to raise awareness and improve access to this critical tool for managing and preventing cancer. It is imperative that we continue to promote this vital aspect of cancer treatment and care for all those affected by breast cancer.


According to

The material in this article is written on the basis of another article.

Leave a Reply

Your email address will not be published. Required fields are marked *